![]() They are not historical facts, nor are they guarantees of future performance. In some cases, you can identify forward-looking statements by the following words: "may," "might," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "seek," "believe," "estimate," "predict," "potential," "continue," "contemplate," "possible" or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. ![]() This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Abcam's American Depositary Shares (ADSs) trade on the Nasdaq Global Select Market (Nasdaq: ABCM).įor more information, please visit Forward-Looking Statements A transparent program of customer reviews and datasheets, combined with industry-leading validation initiatives, gives researchers increased confidence in their results.įounded in 1998 and headquartered in Cambridge, UK, the Company has served customers in more than 130 countries. By actively listening to and collaborating with these researchers, the Company continuously advances its portfolio to address their needs. Providing the research and clinical communities with tools and scientific support, the Company offers highly validated antibodies, assays, and other research tools to address important targets in critical biological pathways.Īlready a pioneer in data sharing and ecommerce in the life sciences, Abcam's ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health.Ībcam's worldwide customer base of approximately 750,000 life science researchers' uses Abcam's antibodies, reagents, biomarkers, and assays. Abcam does not intend to comment further on this strategic review process and will make further announcements in accordance with its ongoing disclosure obligations and pursuant to applicable laws and regulations.Īs an innovator in reagents and tools, Abcam's purpose is to serve life science researchers globally to achieve their mission faster. There can be no assurance regarding the results or outcome of this review. Latham & Watkins has been appointed as legal advisor in connection with the review process. ![]() ![]() ![]() The Board of Directors has retained Lazard and Morgan Stanley as financial advisors to assist in its review of strategic alternatives. We will pursue the pathway that maximizes value for our shareholders and also ensures successful outcomes for our customers and employees." Our Board is fully aligned in its belief that the best way to maximize value for shareholders is to comprehensively review the Company's strategic alternatives, including a potential sale of Abcam. The Company commented: "Abcam is a unique asset that provides innovative products and solutions for the global life sciences community. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |